Sarcoidosis MRI
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Roshan Dinparasti Saleh
Overview
Overview
Currently, cardiac MRI(CMR) is the technique of choice in diagnosis of subclinical or clinical cardiac sarcoidosis. It is fast, accurate, and noninvasive.
MRI
MRI
Currently, cardiac MRI and/or PET scanning is proposed to be most specific for diagnosis of cardiac sarcoidosis[1]. T1-weighted MR shows :
- wall motion abnormalities
- Hypertrophy due to infiltration
- Wall thinning
- Heart failure
- Late gadolinium enhancement (delayed enhancement) evaluates scar/fibrosis and can differentiate chronic versus active disease. Some studies also suggest that monitoring gadolinium enhancement may be helpful in the assessment of response to treatment with steroids[2][3][4].
References
References
- ↑ Hamzeh NY, Wamboldt FS, Weinberger HD: Management of cardiac sarcoidosis in the United States: a Delphi study. Chest 2012, 141(1):154-162.
- ↑ Abrishami B, O’Connel C, Sharma O: Cardiac sarcoidosis with presentation of large left atrial mass. Current opinion in pulmonary medicine 2004, 10(5):397-400.
- ↑ Youssef G, Beanlands RS, Birnie DH, Nery PB: Cardiac sarcoidosis: applications of imaging in diagnosis and directing treatment. Heart (British Cardiac Society) 2011, 97(24):2078-2087.
- ↑ Yeboah J, Lee C, Sharma OP: Cardiac sarcoidosis: a review 2011. Current opinion in pulmonary medicine 2011, 17(5):308-315.
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH